How Genomics and Clinical Data Intertwine

John Quackenbush Harvard, John Quackenbush Dana Farber

John Quackenbush, Ph.D.

John Quackenbush, Ph.D., is a leader in genomics research.  A professor of Computational Biology and Bioinformatics and Principal Investigator at the Harvard School of Public Health and the Dana-Farber Cancer Institute,  he recently spoke with us to discuss the latest research on how genes can influence patient care.

By using better diagnostics, we’ll be able to better predict the progression of disease and be able to create treatment plans with better outcomes for patients.  Watch the video below for more specifics.


Some of the topics covered with Dr. Quackenbush include some pointed commentary, including:

  • Genomics isn’t Big Data, but that’s not the point
  • The complex relationship between genetics and  disease
  • Is it too early for consumer genetics?
  • How research of future treatments can help clinicians today
  • Obesity, diabetes and genetics
  • Obamacare, funding and the state of research

Sermo Speaker Series

A fixture of Sermo for several years, our Speaker Series brings experts from around the healthcare industry to provide exclusive content to Sermo and its membership.  This blog post is a preview of a more in-depth Speaker Series engagement Dr. Quackenbush will be providing as he engages our members directly in a few weeks.

What do you think about genomics in the clinical setting?  Have you used it in your practice to help your patients?  Are you looking forward to what will come down the road in just a few years?  If you’re an M.D. or D.O., please join our upcoming Sermo Speaker Series discussion and other conversations inside Sermo.



Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>